Hemoglobin A2

B-Thal

Hemoglobin A2 (HbA2) is a form of hemoglobin that is found in small amounts in the red blood cells of adults. It is composed of two alpha and two delta chains (α2δ2) and constitutes about 2-3% of the total hemoglobin in individuals without hemoglobinopathies. The measurement of HbA2 levels is crucial in the diagnosis of beta-thalassemia, a blood disorder characterized by the reduced production of the beta globin chain of hemoglobin.

Structure and Function

Hemoglobin is a protein in red blood cells responsible for transporting oxygen from the lungs to the rest of the body and returning carbon dioxide from the body to the lungs to be exhaled. Hemoglobin A2, though present in much smaller quantities compared to the predominant Hemoglobin A (HbA), which consists of two alpha and two beta chains (α2β2), plays a role in the oxygen-carrying function of blood.

Clinical Significance

The clinical significance of HbA2 lies primarily in its role as a diagnostic marker for beta-thalassemia. In individuals with beta-thalassemia, the production of beta globin chains is impaired, leading to an imbalance in the alpha to beta globin ratio. This imbalance results in an increase in the proportion of HbA2 (and also HbF) as the body attempts to compensate for the reduced beta globin production.

1. 1. 1. Beta-Thalassemia Diagnosis

The diagnosis of beta-thalassemia often involves blood tests to measure the levels of various forms of hemoglobin. An elevated HbA2 level, typically greater than 3.5% of total hemoglobin, is indicative of beta-thalassemia. However, it is important to note that the exact cutoff value can vary depending on the laboratory and the method used for measurement.

Genetics

The genes responsible for the production of delta and alpha chains in hemoglobin A2 are located on chromosome 16 and chromosome 11, respectively. Mutations or deletions in these genes can affect the production of HbA2, although such genetic changes are rare compared to those affecting the beta globin gene.

Treatment and Management

There is no specific treatment targeting HbA2 levels in beta-thalassemia or other hemoglobinopathies. Instead, treatment focuses on managing the symptoms and complications of the underlying condition. This may include regular blood transfusions, iron chelation therapy to remove excess iron from the body, and in some cases, bone marrow transplantation.

Conclusion

Hemoglobin A2, while only a minor component of total hemoglobin, plays a significant role in the diagnosis of beta-thalassemia. Its measurement is a key part of the diagnostic process for this condition, helping to differentiate it from other hemoglobinopathies and anemias. Understanding the structure, function, and clinical significance of HbA2 is essential for healthcare professionals involved in the care of patients with blood disorders.

‎